UBS downgraded Molina Healthcare (NYSE: MOH) from Buy to Neutral with a price target of $54.00 (from $76.00) following Q1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE